NPPB and coronary artery disorder: However, lower concentrations of SFRP5 have been demonstrated in coronary artery disease (CAD) [33] as well as higher levels of SFRP5 in chronic heart failure, measured by left ventricular end diastolic diameter (LVEDD) or levels of NT-proBNP [36].